Curis Lifesciences IPO — Listing Performance
Curis Lifesciences IPO facts & figures
| Issue category | SME |
|---|---|
| Issue open date | 7 Nov 2025 |
| Listing date | 14 Nov 2025 |
| Overall subscription | 69.25x |
| Issue price | ₹128 |
| Listing-day close | ₹141 (10.16%) |
| Recent market price | ₹198.35 (54.96% vs issue) |
| 52-week range | ₹88.80 – ₹198.80 |
| Identifiers | NSE: CURIS · ISIN: INE1BZN01016 |
How the listing went
Curis Lifesciences saw a healthy listing pop, closing day one 10.16% above the issue price, after heavy overall subscription of 69.25x.
Curis Lifesciences against every other debut on record
- Rank in 2025: 87 of 215 NSE debuts, on a 10.16% first-day close.
- 57th percentile of 116 SME debuts in 2025 (median 6.52%).
- 7th of 16 debuts in November 2025.
- Subscribed 69.25x: 71st percentile of 165 SME issues with a figure; the 15 subscribed between 50 and 100 times closed day one a median 10.16%.
- Opened 14.14% above issue, then gave up 3.98 points to the close.
- Day-one range ₹138.80 to ₹147.90: a 7.11% swing on the issue price.
- Last close ₹198.35 (11 Sep 2026): 54.96% above issue, against 10.16% on day one.
- 1% up its 52-week range of ₹88.80 to ₹198.80.
- Priced at the top of the ₹120 to ₹128 band.
- Listed 3 calendar days after close.
- All 601 SME debuts on record: median 14.22%, 79% closed above issue.
Computed over 1109 verified NSE debuts to 11 Sep 2026 · sources